Cytopenia Management of Low Risk MDS, or Myelodysplastic Syndromes @AAMDSIF

Cytopenia Management of Low Risk MDS, or Myelodysplastic Syndromes @AAMDSIF

Uploaded April 2026 | Updated September 2026, 20 hours ago

In this webinar, Dr. Abhay Singh will discusses the treatment management of low blood counts for patients with low risk MDS. The recording includes a question and answer segment.
#MDS #lowriskMDS #bloodcancer

Cytopenia Management of Low Risk MDS, or Myelodysplastic Syndromes

Athletic Service Member Conquers Aplastic Anemia and MDS with Transplant

AAMDSIF 40th Anniversary Summit: The Future of Clinical Trials Panel Discussion

Treatment Decisions in Chronic GVHD

CLONALITY IN ACQUIRED BONE MARROW FAILURE, PNH, VEXAS

AAMDSIF 40th Anniversary Summit: Advances in the Science and Treatment of Aplastic Anemia

Grant Impact Story: Dr. Matthew Walter

Living with PNH from the 2022 Buffalo Patient and Family Conference, presented by Bart Scott, MD

Pediatric PNH Diagnosis and Treatment

Cytopenia Management of Low Risk MDS, or Myelodysplastic Syndromes